Programmed cell death ligand 1 (PD-L1) has already been detected in various carcinomas. In nonHodgkin lymphoma (NHL), however, the prognostic value of PD-L1 overexpression remains unclear. | Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma A meta-analysis